SlideShare a Scribd company logo
1 of 34
Download to read offline
Clinical Implications of
Oral Anti-Coagulants
Focus on Atrial Fibrillation
Brad Angeja, MD FACC
Palo Alto Medical Foundation
None
Disclosures
Relevant Advances in Atrial
Fibrillation
• Why anti-coagulate?
– Calculate stroke risk
• Data for warfarin
• Rationale for warfarin alternatives
– Data for the NOACs
– Idiosyncrasies of the NOACs
• Special topics
– Elderly, peri-operative, valves, reversal
Objectives
Clinical Uses of Anti-coagulation
• DVT, PE (discussed separately)
• Mechanical valves
• Atrial fibrillation
– 2.7 million American adults – and counting
– 12% 75 to 84 years of age
– >1/3 ≥80 years of age
– Lifetime risk after 40 years of age is about 25%
• Stroke in AF
– 15% of all strokes in the US can be attributed to AF,
– 5 fold increased risk of stroke and
– the results of stroke are worse 1 ,3
1. Nattel. Lancet 2006;367:262-272
2. Page. N Engl J Med 2004;351:2408-16
3. HRS guidelines 2014
Slide courtesy Chris Woods, MD
Stroke is caused by thromboembolic
disease in AF
5
90% of thrombi are
found in the
Left atrial appendage
Slide courtesy Chris Woods, MD
Transesophageal Echocardiogram of the
Appendage
6
Normal With Clot
Slide courtesy Chris Woods, MD
Slide courtesy Chris Woods, MD
Warfarin works
8
Narrow
Therapeutic
Window
9
Bleeding Risk: HAS-BLED
10
Clinical characteristics comprising the HAS-BLED Bleeding Risk Score
Letter Clinical characteristic* Points HAS-BLED score
Bleeds per 100 patient-yrs
H Hypertension (ie uncontrolled blood pressure) 1 0 1.13
A Abnormal renal and liver function (1 point each) 1 or 2 1 1.02
S Stroke 1 2 1.88
B Bleeding tendency or predisposition 1 3 3.74
L Labile INRs (for patients taking warfarin) 1 4 8.70
E Elderly (age greater than 65 years) 1 5 to 9 Insufficient data
D Drugs (aspirin or NSAIDs) or alcohol abuse (1 point each)
INR: international normalized ratio; NSAIDs: nonsteroidal anti-inflammatory drugs.
“There’s an app for that”
• Online and smartphone calculators
• https://itunes.apple.com/us/app/anticoagevaluato
r/id609795286?mt=8
11
12
13
Warfarin works, but…
• Bleeding risk
• Lab monitoring
• Drug interactions
• Food interactions
• Infrastructure
– Coumadin clinic
• Compliance
Enter: NOACs
• Novel Oral Anti-Coags
14
The Challenge for NOACs
• Must be
– better than warfarin, and/or
– safer than warfarin, and/or
– more convenient than warfarin
• At least enough to justify the cost
• For all it’s problems, warfarin sets a high bar
– 2/3 risk reduction
– Works for 2/3 of patients (INR at target)
– Cheap
15
18,113
CHADS 2
Slide courtesy Chris Woods, MD
17
N=14,266
CHADS 3.5
“As treated”
Slide courtesy Chris Woods, MD
18,201
CHADS 2
Slide courtesy Chris Woods, MD
RE-LY
Dabigatran 110 mg 1.53% per year
Dabigatran 150 mg 1.11% per year
Warfarin 1.69% per year
ROCKET AF
Rivaroxaban 20mg 1.7% per year (2.1)
Warfarin 2.2% per year (2.4) (HR = 0.88) (P=0.12 ITT)
ARISTOTLE
Apixaban 5 mg 1.27% per year
Warfarin 1.60% per year
Primary Endpoint of Stroke or Systemic
Embolism: Non-inferiority Analysis
p<0.001
p<0.001
p<0.001
Non Inferiorirty
p vs warfarin
ITT Analysis
Modified ITT
No ITT analysis is available for non-inferiority in Rocket AF. An on treatment or per-protocol analysis is generally performed in the
assessment of non-inferiority. If numerous patients come off of study drug, this biases the trial towards a non-inferior result in an ITT
analysis. This is the basis for performing a per-protocol analysis in a non-inferiority assessment.
C. Michael Gibson, M.S., M.D.
p<0.001
ITT Analysis
Patel MR et al, NEJM 2011; Connolly SJ, et al. N Engl J Med. 2009;361:1139-1151; Granger C et al, N Eng J Med; 2011
HR = 0.79
HR = 0.79
HR = 0.91
HR = 0.66
Slide modified from Chris Woods, MD
20
All Cause Stroke
Ischemic Stroke
Hemorrhagic stroke
Slide courtesy Chris Woods, MD
All Cause Mortality favors NOAC
Dabigatran 110 mg 3.75% / yr 0.91 0.35
Dabigatran 150 mg 3 .64% / yr 0.88 0.051
Warfarin 4.13% / yr
HR ITT
p-value
Rivaroxaban 20 mg 4.52% / yr 0.92 0.152*
Warfarin 4.91% / yr
ROCKET
RELY
C. Michael Gibson, M.S., M.D.
*In an on treatment analysis in Rocket AF mortality rates were 1.87% / yr for rivaroxaban and 2.21% / yr for
warfarin, p=0.073. No on treatment analysis is available from RE-LY.
Apixaban 5 mg 3.52% / yr 0.89 0.01
Warfarin 3.94% / yr
ARISTOTLE
Patel MR et al, NEJM 2011; Connolly SJ, et al. N Engl J Med. 2009;361:1139-1151; Granger C et al, N Eng J Med; 2011
95% CI 0.89 (0.80, 0.998)
N=448 events planned, 480 in trial
Slide courtesy Chris Woods, MD
22
Efficacy
• Eliquis
• Pradaxa
• Xarelto
Convenience
• Xarelto
• Eliquis
• Pradaxa
Safety
• Eliquis
• Xarelto
• Pradaxa
23
24
25
Safety concerns re: Pradaxa
• GI side effects in 25-35%
– Including significantly more GI bleeding
• Not advised in patients over 80
• 75 mg “dose adjustment” for renal dysfunction
– Not validated in Re-Ly!
– Generally avoid this agent if CrCl is under 30
• Small increase in MI risk?
– Did not reach statistical significance
– But – I have seen 2 cases…
26
Fewer safety concerns re: Xarelto
• No GI side effects
• Acceptable in patients over 80
• Dose adjustment for renal dysfunction
– 15mg daily if CrCl is 15-50
– Must calculate Cockcroft-Gault!
• Estimated GFR from lab varies from CrCl
27
Fewest safety concerns re: Eliquis
• No GI side effects
• Acceptable in patients over 80
• Dose adjustment if any 2 of 3 are present:
– Renal dysfunction (Cr > 1.5)
• Including ESRD (although still consider warfarin)
• No need to calculate Cockcroft-Gault
– Weight under 60kg
– Age > 80
28
29
Efficacy
• Eliquis
• Pradaxa
• Xarelto
Convenience
• Xarelto
• Eliquis
• Pradaxa
Safety
• Eliquis
• Xarelto
• Pradaxa
I favor Eliquis unless:
• Once-daily preferred
• Formulary requires
Special Considerations: Peri-operative
• Low-bleed risk
– Continue if possible
• Intermediate risk
– Stop the day prior
• High bleed risk
– Stop 2 days prior
• Refer to manufacturer
recommendations
• Ask us!
• Warfarin, Eliquis,
Xarelto, plavix, ASA,
prasugrel…
• No “one size fits all”
for pre-op!
– Old standard:
• “Stop blood thinners 1
week prior”
– In 2015:
• “Please consult with the
prescribing physician”
30
Special Considerations: Bleeding
• “Warfarin can be reversed, NOACs cannot”
– How effective is plasma and Vit K anyway?
– Short half-life – NOACs “wear off” quickly
– No antidote in the clinical trials of NOACs, and they
were equal to or better than warfarin bleed risk!
– Reversal agents are on the way
31
Special Considerations: Warfarin only
• Valvular AF
– In particular when the AF is related to the valve (mitral)
– Less strict if the valve is dissociated from the AF (AS)
• Mechanical valves
• “Triple Therapy”
– AF with high CVA risk PLUS recent ACS or stent
– Aspirin, plavix, warfarin – best determined by
interventional cardiologist
32
Making the switch
• Warfarin to NOACs
– Stop warfarin
– INR drifts down; intend to start NOAC when INR < 2
• Measure every day, or
• Typically skip 2 days if INR has been predictable 2.5
• NOACs to warfarin
– More complicated
– Generally requires enoxaparin to replace the NOAC
while warfarin gets to INR > 2
• NOACs can affect INR
33
Relevant Advances in Atrial
Fibrillation
• Anti-coagulation reduces stroke risk in AF
– CHADS-VASC and HAS-BLED
– “There’s an app for that”
• Warfarin is very good – NOACs are better
– Eliquis > Xarelto > Pradaxa
– Except valves and “triple therapy”
• Peri-op – tailor the “holiday” to the agent!
Summary

More Related Content

What's hot

Dyslipidemia and CVS by Mohit Soni and Chandan Kumar
Dyslipidemia and CVS by Mohit Soni and Chandan KumarDyslipidemia and CVS by Mohit Soni and Chandan Kumar
Dyslipidemia and CVS by Mohit Soni and Chandan KumarOlgaGoryacheva4
 
Journal-Club-final-1
Journal-Club-final-1Journal-Club-final-1
Journal-Club-final-1Mohammed Adel
 
PROTECT-AF trial - Summary & Results
PROTECT-AF trial - Summary & ResultsPROTECT-AF trial - Summary & Results
PROTECT-AF trial - Summary & Resultstheheart.org
 
Breaking the-cardiovascular-disease-continuum
Breaking the-cardiovascular-disease-continuumBreaking the-cardiovascular-disease-continuum
Breaking the-cardiovascular-disease-continuumKadarabadNarsingarao
 
New Oral anticoagulants
New Oral anticoagulantsNew Oral anticoagulants
New Oral anticoagulantsDiya Saleh
 
Antiplatelet agents in acute coronary syndrome
Antiplatelet agents in acute coronary syndromeAntiplatelet agents in acute coronary syndrome
Antiplatelet agents in acute coronary syndromesalahabusin
 
New Option of Antiplatelet and Controversies in ACS Treatment
New Option of Antiplatelet and Controversies in ACS TreatmentNew Option of Antiplatelet and Controversies in ACS Treatment
New Option of Antiplatelet and Controversies in ACS TreatmentPERKI Pekanbaru
 
Dapt vs triple therapy, jacc
Dapt vs triple therapy, jaccDapt vs triple therapy, jacc
Dapt vs triple therapy, jaccKhushboo Gandhi
 
Platelet Aggregation Inhibitor Ticagrelor(274693-27-5) for sale
Platelet Aggregation Inhibitor Ticagrelor(274693-27-5) for salePlatelet Aggregation Inhibitor Ticagrelor(274693-27-5) for sale
Platelet Aggregation Inhibitor Ticagrelor(274693-27-5) for saleticagrelor
 
Trv027 a biased ligand approach to improve outcomes.
Trv027 a biased ligand approach to improve outcomes.Trv027 a biased ligand approach to improve outcomes.
Trv027 a biased ligand approach to improve outcomes.Mukesh Mishra
 
Anti-platlets from clopidogrel to the new agents
Anti-platlets from clopidogrel to the new agentsAnti-platlets from clopidogrel to the new agents
Anti-platlets from clopidogrel to the new agentsAshraf Reda
 
AHF - Discharge from ICU to the Regular Ward.
AHF - Discharge from ICU to the Regular Ward.AHF - Discharge from ICU to the Regular Ward.
AHF - Discharge from ICU to the Regular Ward.drucsamal
 
Hot Topics in Critical Care - March 2017
Hot Topics in Critical Care - March 2017Hot Topics in Critical Care - March 2017
Hot Topics in Critical Care - March 2017Steve Mathieu
 
TAVR SAVR evolution of a groundbreaking therapy
TAVR SAVR evolution of a groundbreaking therapyTAVR SAVR evolution of a groundbreaking therapy
TAVR SAVR evolution of a groundbreaking therapyLuisArturo RV
 
Practical application of anticoagulation therapy af and vte april 12
Practical application of  anticoagulation therapy af and vte april 12Practical application of  anticoagulation therapy af and vte april 12
Practical application of anticoagulation therapy af and vte april 12Ihsaan Peer
 

What's hot (20)

Dyslipidemia and CVS by Mohit Soni and Chandan Kumar
Dyslipidemia and CVS by Mohit Soni and Chandan KumarDyslipidemia and CVS by Mohit Soni and Chandan Kumar
Dyslipidemia and CVS by Mohit Soni and Chandan Kumar
 
Journal-Club-final-1
Journal-Club-final-1Journal-Club-final-1
Journal-Club-final-1
 
PROTECT-AF trial - Summary & Results
PROTECT-AF trial - Summary & ResultsPROTECT-AF trial - Summary & Results
PROTECT-AF trial - Summary & Results
 
Pegasus
PegasusPegasus
Pegasus
 
Breaking the-cardiovascular-disease-continuum
Breaking the-cardiovascular-disease-continuumBreaking the-cardiovascular-disease-continuum
Breaking the-cardiovascular-disease-continuum
 
Anticoag update sept 2018
Anticoag update sept 2018Anticoag update sept 2018
Anticoag update sept 2018
 
New Oral anticoagulants
New Oral anticoagulantsNew Oral anticoagulants
New Oral anticoagulants
 
Dual Therapy with Aspirin and Rivaroxaban -Dr. Verhamme
Dual Therapy with Aspirin and Rivaroxaban -Dr. VerhammeDual Therapy with Aspirin and Rivaroxaban -Dr. Verhamme
Dual Therapy with Aspirin and Rivaroxaban -Dr. Verhamme
 
Antiplatelet agents in acute coronary syndrome
Antiplatelet agents in acute coronary syndromeAntiplatelet agents in acute coronary syndrome
Antiplatelet agents in acute coronary syndrome
 
New Option of Antiplatelet and Controversies in ACS Treatment
New Option of Antiplatelet and Controversies in ACS TreatmentNew Option of Antiplatelet and Controversies in ACS Treatment
New Option of Antiplatelet and Controversies in ACS Treatment
 
Dapt vs triple therapy, jacc
Dapt vs triple therapy, jaccDapt vs triple therapy, jacc
Dapt vs triple therapy, jacc
 
CONTROVERSIES FOR ASIAN PATIENTS
CONTROVERSIES FOR ASIAN PATIENTSCONTROVERSIES FOR ASIAN PATIENTS
CONTROVERSIES FOR ASIAN PATIENTS
 
Platelet Aggregation Inhibitor Ticagrelor(274693-27-5) for sale
Platelet Aggregation Inhibitor Ticagrelor(274693-27-5) for salePlatelet Aggregation Inhibitor Ticagrelor(274693-27-5) for sale
Platelet Aggregation Inhibitor Ticagrelor(274693-27-5) for sale
 
Trv027 a biased ligand approach to improve outcomes.
Trv027 a biased ligand approach to improve outcomes.Trv027 a biased ligand approach to improve outcomes.
Trv027 a biased ligand approach to improve outcomes.
 
Anti-platlets from clopidogrel to the new agents
Anti-platlets from clopidogrel to the new agentsAnti-platlets from clopidogrel to the new agents
Anti-platlets from clopidogrel to the new agents
 
Ticagrelor
TicagrelorTicagrelor
Ticagrelor
 
AHF - Discharge from ICU to the Regular Ward.
AHF - Discharge from ICU to the Regular Ward.AHF - Discharge from ICU to the Regular Ward.
AHF - Discharge from ICU to the Regular Ward.
 
Hot Topics in Critical Care - March 2017
Hot Topics in Critical Care - March 2017Hot Topics in Critical Care - March 2017
Hot Topics in Critical Care - March 2017
 
TAVR SAVR evolution of a groundbreaking therapy
TAVR SAVR evolution of a groundbreaking therapyTAVR SAVR evolution of a groundbreaking therapy
TAVR SAVR evolution of a groundbreaking therapy
 
Practical application of anticoagulation therapy af and vte april 12
Practical application of  anticoagulation therapy af and vte april 12Practical application of  anticoagulation therapy af and vte april 12
Practical application of anticoagulation therapy af and vte april 12
 

Viewers also liked

Complications & management
Complications & managementComplications & management
Complications & managementeh8922
 
ANTI-COAGULANTS: A PRECISE OUTLOOK.........By Rxvichu!!! :)
ANTI-COAGULANTS: A PRECISE OUTLOOK.........By Rxvichu!!! :)ANTI-COAGULANTS: A PRECISE OUTLOOK.........By Rxvichu!!! :)
ANTI-COAGULANTS: A PRECISE OUTLOOK.........By Rxvichu!!! :)RxVichuZ
 
Clotting disorders 1/ dental implant courses
Clotting disorders 1/ dental implant coursesClotting disorders 1/ dental implant courses
Clotting disorders 1/ dental implant coursesIndian dental academy
 
Hematology%20disorder%20in%20dental%20treatment[1]
Hematology%20disorder%20in%20dental%20treatment[1]Hematology%20disorder%20in%20dental%20treatment[1]
Hematology%20disorder%20in%20dental%20treatment[1]Edgar Javier Majano B
 
Medical conditions that can directly affect the provision of dental care and/...
Medical conditions that can directly affect the provision of dental care and/...Medical conditions that can directly affect the provision of dental care and/...
Medical conditions that can directly affect the provision of dental care and/...Ruhi Kashmiri
 
hematology.wustl.edu/conferences/presentations/bli... hematology.wustl.edu/...
hematology.wustl.edu/conferences/presentations/bli... 	 hematology.wustl.edu/...hematology.wustl.edu/conferences/presentations/bli... 	 hematology.wustl.edu/...
hematology.wustl.edu/conferences/presentations/bli... hematology.wustl.edu/...MedicineAndHealthCancer
 
Oral consideration and laboratory investigations of bleeding and clotting dis...
Oral consideration and laboratory investigations of bleeding and clotting dis...Oral consideration and laboratory investigations of bleeding and clotting dis...
Oral consideration and laboratory investigations of bleeding and clotting dis...kashmira483
 
medicine.Bleeding disorders.(dr.sabir) (new powerpoint)
medicine.Bleeding disorders.(dr.sabir) (new powerpoint)medicine.Bleeding disorders.(dr.sabir) (new powerpoint)
medicine.Bleeding disorders.(dr.sabir) (new powerpoint)student
 
Dental management of Patients taking oral anti-coagulants and Aspirin
Dental management of Patients taking oral anti-coagulants and AspirinDental management of Patients taking oral anti-coagulants and Aspirin
Dental management of Patients taking oral anti-coagulants and AspirinJignesh Patel
 
dental management of a renal disorder patient
dental management of a renal disorder patientdental management of a renal disorder patient
dental management of a renal disorder patientSumaira Saeed
 
management of patients on oral anticoagulants & antiplatelet therapy requirin...
management of patients on oral anticoagulants & antiplatelet therapy requirin...management of patients on oral anticoagulants & antiplatelet therapy requirin...
management of patients on oral anticoagulants & antiplatelet therapy requirin...Muraja
 
Dental management of the hemophilic patient
Dental management of the hemophilic patientDental management of the hemophilic patient
Dental management of the hemophilic patientVibhuti Kaul
 
Management of medically compromised patients
Management of medically compromised patientsManagement of medically compromised patients
Management of medically compromised patientsHesham El-Hawary
 

Viewers also liked (20)

Oral-Anti coagulants
Oral-Anti coagulantsOral-Anti coagulants
Oral-Anti coagulants
 
Complications & management
Complications & managementComplications & management
Complications & management
 
Medicine 5th year, 10th lecture (Dr. Sabir)
Medicine 5th year, 10th lecture (Dr. Sabir)Medicine 5th year, 10th lecture (Dr. Sabir)
Medicine 5th year, 10th lecture (Dr. Sabir)
 
ANTI-COAGULANTS: A PRECISE OUTLOOK.........By Rxvichu!!! :)
ANTI-COAGULANTS: A PRECISE OUTLOOK.........By Rxvichu!!! :)ANTI-COAGULANTS: A PRECISE OUTLOOK.........By Rxvichu!!! :)
ANTI-COAGULANTS: A PRECISE OUTLOOK.........By Rxvichu!!! :)
 
Clotting disorders 1/ dental implant courses
Clotting disorders 1/ dental implant coursesClotting disorders 1/ dental implant courses
Clotting disorders 1/ dental implant courses
 
Hematology%20disorder%20in%20dental%20treatment[1]
Hematology%20disorder%20in%20dental%20treatment[1]Hematology%20disorder%20in%20dental%20treatment[1]
Hematology%20disorder%20in%20dental%20treatment[1]
 
Bleeding disorder
Bleeding disorderBleeding disorder
Bleeding disorder
 
Haemophilia
HaemophiliaHaemophilia
Haemophilia
 
Medical conditions that can directly affect the provision of dental care and/...
Medical conditions that can directly affect the provision of dental care and/...Medical conditions that can directly affect the provision of dental care and/...
Medical conditions that can directly affect the provision of dental care and/...
 
hematology.wustl.edu/conferences/presentations/bli... hematology.wustl.edu/...
hematology.wustl.edu/conferences/presentations/bli... 	 hematology.wustl.edu/...hematology.wustl.edu/conferences/presentations/bli... 	 hematology.wustl.edu/...
hematology.wustl.edu/conferences/presentations/bli... hematology.wustl.edu/...
 
Oral consideration and laboratory investigations of bleeding and clotting dis...
Oral consideration and laboratory investigations of bleeding and clotting dis...Oral consideration and laboratory investigations of bleeding and clotting dis...
Oral consideration and laboratory investigations of bleeding and clotting dis...
 
medicine.Bleeding disorders.(dr.sabir) (new powerpoint)
medicine.Bleeding disorders.(dr.sabir) (new powerpoint)medicine.Bleeding disorders.(dr.sabir) (new powerpoint)
medicine.Bleeding disorders.(dr.sabir) (new powerpoint)
 
Dental management of Patients taking oral anti-coagulants and Aspirin
Dental management of Patients taking oral anti-coagulants and AspirinDental management of Patients taking oral anti-coagulants and Aspirin
Dental management of Patients taking oral anti-coagulants and Aspirin
 
Anticoagulants (VK)
Anticoagulants (VK)Anticoagulants (VK)
Anticoagulants (VK)
 
dental management of a renal disorder patient
dental management of a renal disorder patientdental management of a renal disorder patient
dental management of a renal disorder patient
 
CME: Bleeding Disorders - Management
CME: Bleeding Disorders - ManagementCME: Bleeding Disorders - Management
CME: Bleeding Disorders - Management
 
management of patients on oral anticoagulants & antiplatelet therapy requirin...
management of patients on oral anticoagulants & antiplatelet therapy requirin...management of patients on oral anticoagulants & antiplatelet therapy requirin...
management of patients on oral anticoagulants & antiplatelet therapy requirin...
 
Anti coagulants
Anti coagulantsAnti coagulants
Anti coagulants
 
Dental management of the hemophilic patient
Dental management of the hemophilic patientDental management of the hemophilic patient
Dental management of the hemophilic patient
 
Management of medically compromised patients
Management of medically compromised patientsManagement of medically compromised patients
Management of medically compromised patients
 

Similar to Clinical Implications of Oral Anti-Coagulants

Cadth 2015 e5 noac ad symposium_panel_14apr2015
Cadth 2015 e5 noac ad symposium_panel_14apr2015Cadth 2015 e5 noac ad symposium_panel_14apr2015
Cadth 2015 e5 noac ad symposium_panel_14apr2015CADTH Symposium
 
Cardiovascular Medications in Older Adults
Cardiovascular Medications in Older Adults  Cardiovascular Medications in Older Adults
Cardiovascular Medications in Older Adults PASaskatchewan
 
Anticoagulation in chronic kidney disease
Anticoagulation in chronic kidney diseaseAnticoagulation in chronic kidney disease
Anticoagulation in chronic kidney diseaseFarragBahbah
 
Afib and Stroke Prevention Update
Afib and Stroke Prevention UpdateAfib and Stroke Prevention Update
Afib and Stroke Prevention UpdateJose Osorio
 
Managing the heart value
Managing the heart valueManaging the heart value
Managing the heart valueNarayana Health
 
Anticoagulation in chronic kidney disease dr. mohsen el kossi
Anticoagulation in chronic kidney disease dr. mohsen el kossiAnticoagulation in chronic kidney disease dr. mohsen el kossi
Anticoagulation in chronic kidney disease dr. mohsen el kossiFarragBahbah
 
Anticoagulation Reversal
Anticoagulation ReversalAnticoagulation Reversal
Anticoagulation ReversalderosaMSKCC
 
udaipur 19.11.2022 noac.pptx
udaipur 19.11.2022 noac.pptxudaipur 19.11.2022 noac.pptx
udaipur 19.11.2022 noac.pptxKush Bhagat
 
Stroke Prevention in Atrial Fibrillation
Stroke Prevention in Atrial FibrillationStroke Prevention in Atrial Fibrillation
Stroke Prevention in Atrial FibrillationGillian Gordon Perue
 
Speaker 1_Clinical Care of Elderly Patients with NVAF-1.pptx
Speaker 1_Clinical Care of Elderly Patients with NVAF-1.pptxSpeaker 1_Clinical Care of Elderly Patients with NVAF-1.pptx
Speaker 1_Clinical Care of Elderly Patients with NVAF-1.pptxSharatVijapur1
 
Thromboembolic prevention in elderly
Thromboembolic prevention in elderlyThromboembolic prevention in elderly
Thromboembolic prevention in elderlyMohamed Attia
 
DR Muller
DR MullerDR Muller
DR MullerFHA321
 
ASandler_JC_Invictus.docx
ASandler_JC_Invictus.docxASandler_JC_Invictus.docx
ASandler_JC_Invictus.docxAnnaSandler4
 
Anticoagulation in atrial fibrillation
Anticoagulation in atrial fibrillationAnticoagulation in atrial fibrillation
Anticoagulation in atrial fibrillationMashiul Alam
 

Similar to Clinical Implications of Oral Anti-Coagulants (20)

Cadth 2015 e5 noac ad symposium_panel_14apr2015
Cadth 2015 e5 noac ad symposium_panel_14apr2015Cadth 2015 e5 noac ad symposium_panel_14apr2015
Cadth 2015 e5 noac ad symposium_panel_14apr2015
 
Afib NOAC residency pres
Afib NOAC residency presAfib NOAC residency pres
Afib NOAC residency pres
 
NOAC.pdf
NOAC.pdfNOAC.pdf
NOAC.pdf
 
Cardiovascular Medications in Older Adults
Cardiovascular Medications in Older Adults  Cardiovascular Medications in Older Adults
Cardiovascular Medications in Older Adults
 
Anticoagulation in chronic kidney disease
Anticoagulation in chronic kidney diseaseAnticoagulation in chronic kidney disease
Anticoagulation in chronic kidney disease
 
Afib guidelines
Afib guidelinesAfib guidelines
Afib guidelines
 
Afib and Stroke Prevention Update
Afib and Stroke Prevention UpdateAfib and Stroke Prevention Update
Afib and Stroke Prevention Update
 
Managing the heart value
Managing the heart valueManaging the heart value
Managing the heart value
 
Anticoagulation in chronic kidney disease dr. mohsen el kossi
Anticoagulation in chronic kidney disease dr. mohsen el kossiAnticoagulation in chronic kidney disease dr. mohsen el kossi
Anticoagulation in chronic kidney disease dr. mohsen el kossi
 
Anticoagulation Reversal
Anticoagulation ReversalAnticoagulation Reversal
Anticoagulation Reversal
 
udaipur 19.11.2022 noac.pptx
udaipur 19.11.2022 noac.pptxudaipur 19.11.2022 noac.pptx
udaipur 19.11.2022 noac.pptx
 
AF in elderly
AF in elderly AF in elderly
AF in elderly
 
Stroke Prevention in Atrial Fibrillation
Stroke Prevention in Atrial FibrillationStroke Prevention in Atrial Fibrillation
Stroke Prevention in Atrial Fibrillation
 
Speaker 1_Clinical Care of Elderly Patients with NVAF-1.pptx
Speaker 1_Clinical Care of Elderly Patients with NVAF-1.pptxSpeaker 1_Clinical Care of Elderly Patients with NVAF-1.pptx
Speaker 1_Clinical Care of Elderly Patients with NVAF-1.pptx
 
Thromboembolic prevention in elderly
Thromboembolic prevention in elderlyThromboembolic prevention in elderly
Thromboembolic prevention in elderly
 
DR Muller
DR MullerDR Muller
DR Muller
 
Atrial fibrillation
Atrial fibrillationAtrial fibrillation
Atrial fibrillation
 
ASandler_JC_Invictus.docx
ASandler_JC_Invictus.docxASandler_JC_Invictus.docx
ASandler_JC_Invictus.docx
 
Dr. Ganasani
Dr. GanasaniDr. Ganasani
Dr. Ganasani
 
Anticoagulation in atrial fibrillation
Anticoagulation in atrial fibrillationAnticoagulation in atrial fibrillation
Anticoagulation in atrial fibrillation
 

More from Peninsula Coastal Region of Sutter Health

Surgery, radiation therapy or neither evolving approaches to prostate cance...
Surgery, radiation therapy or neither   evolving approaches to prostate cance...Surgery, radiation therapy or neither   evolving approaches to prostate cance...
Surgery, radiation therapy or neither evolving approaches to prostate cance...Peninsula Coastal Region of Sutter Health
 
Ventricular Arrhythmias: Ablating Our Way Out of Cardiomyopathy and Sudden Ca...
Ventricular Arrhythmias: Ablating Our Way Out of Cardiomyopathy and Sudden Ca...Ventricular Arrhythmias: Ablating Our Way Out of Cardiomyopathy and Sudden Ca...
Ventricular Arrhythmias: Ablating Our Way Out of Cardiomyopathy and Sudden Ca...Peninsula Coastal Region of Sutter Health
 
Treatment of brain malignancies and other brain lesions: Emergence of stereo...
Treatment of brain malignancies and other brain lesions:  Emergence of stereo...Treatment of brain malignancies and other brain lesions:  Emergence of stereo...
Treatment of brain malignancies and other brain lesions: Emergence of stereo...Peninsula Coastal Region of Sutter Health
 

More from Peninsula Coastal Region of Sutter Health (15)

Nutrition and cancer
Nutrition and cancerNutrition and cancer
Nutrition and cancer
 
Surgery, radiation therapy or neither evolving approaches to prostate cance...
Surgery, radiation therapy or neither   evolving approaches to prostate cance...Surgery, radiation therapy or neither   evolving approaches to prostate cance...
Surgery, radiation therapy or neither evolving approaches to prostate cance...
 
Updates in cancer genetic testing
Updates in cancer genetic testingUpdates in cancer genetic testing
Updates in cancer genetic testing
 
Low dose ct lung cancer screening update
Low dose ct lung cancer screening updateLow dose ct lung cancer screening update
Low dose ct lung cancer screening update
 
Robotic surgery and cancer gastrointestinal and thoracic
Robotic surgery and cancer  gastrointestinal and thoracicRobotic surgery and cancer  gastrointestinal and thoracic
Robotic surgery and cancer gastrointestinal and thoracic
 
Neoadjuvant treatment for esophageal and gastric cancer
Neoadjuvant treatment for esophageal and gastric cancerNeoadjuvant treatment for esophageal and gastric cancer
Neoadjuvant treatment for esophageal and gastric cancer
 
Antiplatelet Therapy: What’s New, Older Agents and How They Work
Antiplatelet Therapy: What’s New, Older Agents and How They WorkAntiplatelet Therapy: What’s New, Older Agents and How They Work
Antiplatelet Therapy: What’s New, Older Agents and How They Work
 
Ventricular Arrhythmias: Ablating Our Way Out of Cardiomyopathy and Sudden Ca...
Ventricular Arrhythmias: Ablating Our Way Out of Cardiomyopathy and Sudden Ca...Ventricular Arrhythmias: Ablating Our Way Out of Cardiomyopathy and Sudden Ca...
Ventricular Arrhythmias: Ablating Our Way Out of Cardiomyopathy and Sudden Ca...
 
Anticoagulation Pharmacology
Anticoagulation PharmacologyAnticoagulation Pharmacology
Anticoagulation Pharmacology
 
Stereotactic Radiosurgery for Lung Cancer
Stereotactic Radiosurgery for Lung CancerStereotactic Radiosurgery for Lung Cancer
Stereotactic Radiosurgery for Lung Cancer
 
Treatment of brain malignancies and other brain lesions: Emergence of stereo...
Treatment of brain malignancies and other brain lesions:  Emergence of stereo...Treatment of brain malignancies and other brain lesions:  Emergence of stereo...
Treatment of brain malignancies and other brain lesions: Emergence of stereo...
 
Minimally Invasive Liver Resection and Ablation For Malignancy
Minimally Invasive Liver Resection and Ablation For MalignancyMinimally Invasive Liver Resection and Ablation For Malignancy
Minimally Invasive Liver Resection and Ablation For Malignancy
 
“Dense Breasts”: The Facts, The Myths, The Law
“Dense Breasts”: The Facts, The Myths, The Law“Dense Breasts”: The Facts, The Myths, The Law
“Dense Breasts”: The Facts, The Myths, The Law
 
Ovarian Cancer Treatment – The Latest and Greatest
Ovarian Cancer Treatment –  The Latest and GreatestOvarian Cancer Treatment –  The Latest and Greatest
Ovarian Cancer Treatment – The Latest and Greatest
 
Prostate Cancer Screening
Prostate Cancer ScreeningProstate Cancer Screening
Prostate Cancer Screening
 

Recently uploaded

VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591
VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591
VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591adityaroy0215
 
Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...
Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...
Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...Niamh verma
 
VIP Kolkata Call Girl New Town 👉 8250192130 Available With Room
VIP Kolkata Call Girl New Town 👉 8250192130  Available With RoomVIP Kolkata Call Girl New Town 👉 8250192130  Available With Room
VIP Kolkata Call Girl New Town 👉 8250192130 Available With Roomdivyansh0kumar0
 
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...High Profile Call Girls Chandigarh Aarushi
 
Russian Call Girls Kota * 8250192130 Service starts from just ₹9999 ✅
Russian Call Girls Kota * 8250192130 Service starts from just ₹9999 ✅Russian Call Girls Kota * 8250192130 Service starts from just ₹9999 ✅
Russian Call Girls Kota * 8250192130 Service starts from just ₹9999 ✅gragmanisha42
 
Hot Call Girl In Chandigarh 👅🥵 9053'900678 Call Girls Service In Chandigarh
Hot  Call Girl In Chandigarh 👅🥵 9053'900678 Call Girls Service In ChandigarhHot  Call Girl In Chandigarh 👅🥵 9053'900678 Call Girls Service In Chandigarh
Hot Call Girl In Chandigarh 👅🥵 9053'900678 Call Girls Service In ChandigarhVip call girls In Chandigarh
 
❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR Call G...
❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR   Call G...❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR   Call G...
❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR Call G...Gfnyt.com
 
Jalandhar Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...
Jalandhar  Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...Jalandhar  Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...
Jalandhar Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...Call Girls Service Chandigarh Ayushi
 
Leading transformational change: inner and outer skills
Leading transformational change: inner and outer skillsLeading transformational change: inner and outer skills
Leading transformational change: inner and outer skillsHelenBevan4
 
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near MeVIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Memriyagarg453
 
💚😋Chandigarh Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Chandigarh Escort Service Call Girls, ₹5000 To 25K With AC💚😋💚😋Chandigarh Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Chandigarh Escort Service Call Girls, ₹5000 To 25K With AC💚😋Sheetaleventcompany
 
No Advance 9053900678 Chandigarh Call Girls , Indian Call Girls For Full Ni...
No Advance 9053900678 Chandigarh  Call Girls , Indian Call Girls  For Full Ni...No Advance 9053900678 Chandigarh  Call Girls , Indian Call Girls  For Full Ni...
No Advance 9053900678 Chandigarh Call Girls , Indian Call Girls For Full Ni...Vip call girls In Chandigarh
 
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Chandigarh Call Girls 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Chandigarh Call Girls 👙 7001035870 👙 Genuine WhatsApp Number for Real MeetChandigarh Call Girls 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Chandigarh Call Girls 👙 7001035870 👙 Genuine WhatsApp Number for Real Meetpriyashah722354
 
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real MeetCall Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meetpriyashah722354
 
Basics of Anatomy- Language of Anatomy.pptx
Basics of Anatomy- Language of Anatomy.pptxBasics of Anatomy- Language of Anatomy.pptx
Basics of Anatomy- Language of Anatomy.pptxAyush Gupta
 
Bangalore call girl 👯‍♀️@ Simran Independent Call Girls in Bangalore GIUXUZ...
Bangalore call girl  👯‍♀️@ Simran Independent Call Girls in Bangalore  GIUXUZ...Bangalore call girl  👯‍♀️@ Simran Independent Call Girls in Bangalore  GIUXUZ...
Bangalore call girl 👯‍♀️@ Simran Independent Call Girls in Bangalore GIUXUZ...Gfnyt
 

Recently uploaded (20)

VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591
VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591
VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591
 
Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...
Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...
Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...
 
VIP Kolkata Call Girl New Town 👉 8250192130 Available With Room
VIP Kolkata Call Girl New Town 👉 8250192130  Available With RoomVIP Kolkata Call Girl New Town 👉 8250192130  Available With Room
VIP Kolkata Call Girl New Town 👉 8250192130 Available With Room
 
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
 
Russian Call Girls Kota * 8250192130 Service starts from just ₹9999 ✅
Russian Call Girls Kota * 8250192130 Service starts from just ₹9999 ✅Russian Call Girls Kota * 8250192130 Service starts from just ₹9999 ✅
Russian Call Girls Kota * 8250192130 Service starts from just ₹9999 ✅
 
Hot Call Girl In Chandigarh 👅🥵 9053'900678 Call Girls Service In Chandigarh
Hot  Call Girl In Chandigarh 👅🥵 9053'900678 Call Girls Service In ChandigarhHot  Call Girl In Chandigarh 👅🥵 9053'900678 Call Girls Service In Chandigarh
Hot Call Girl In Chandigarh 👅🥵 9053'900678 Call Girls Service In Chandigarh
 
❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR Call G...
❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR   Call G...❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR   Call G...
❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR Call G...
 
Jalandhar Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...
Jalandhar  Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...Jalandhar  Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...
Jalandhar Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...
 
Leading transformational change: inner and outer skills
Leading transformational change: inner and outer skillsLeading transformational change: inner and outer skills
Leading transformational change: inner and outer skills
 
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near MeVIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
 
Call Girl Dehradun Aashi 🔝 7001305949 🔝 💃 Independent Escort Service Dehradun
Call Girl Dehradun Aashi 🔝 7001305949 🔝 💃 Independent Escort Service DehradunCall Girl Dehradun Aashi 🔝 7001305949 🔝 💃 Independent Escort Service Dehradun
Call Girl Dehradun Aashi 🔝 7001305949 🔝 💃 Independent Escort Service Dehradun
 
💚😋Chandigarh Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Chandigarh Escort Service Call Girls, ₹5000 To 25K With AC💚😋💚😋Chandigarh Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Chandigarh Escort Service Call Girls, ₹5000 To 25K With AC💚😋
 
No Advance 9053900678 Chandigarh Call Girls , Indian Call Girls For Full Ni...
No Advance 9053900678 Chandigarh  Call Girls , Indian Call Girls  For Full Ni...No Advance 9053900678 Chandigarh  Call Girls , Indian Call Girls  For Full Ni...
No Advance 9053900678 Chandigarh Call Girls , Indian Call Girls For Full Ni...
 
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girl Guwahati Aashi 👉 7001305949 👈 🔝 Independent Escort Service Guwahati
Call Girl Guwahati Aashi 👉 7001305949 👈 🔝 Independent Escort Service GuwahatiCall Girl Guwahati Aashi 👉 7001305949 👈 🔝 Independent Escort Service Guwahati
Call Girl Guwahati Aashi 👉 7001305949 👈 🔝 Independent Escort Service Guwahati
 
Chandigarh Call Girls 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Chandigarh Call Girls 👙 7001035870 👙 Genuine WhatsApp Number for Real MeetChandigarh Call Girls 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Chandigarh Call Girls 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
 
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real MeetCall Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
 
Basics of Anatomy- Language of Anatomy.pptx
Basics of Anatomy- Language of Anatomy.pptxBasics of Anatomy- Language of Anatomy.pptx
Basics of Anatomy- Language of Anatomy.pptx
 
Bangalore call girl 👯‍♀️@ Simran Independent Call Girls in Bangalore GIUXUZ...
Bangalore call girl  👯‍♀️@ Simran Independent Call Girls in Bangalore  GIUXUZ...Bangalore call girl  👯‍♀️@ Simran Independent Call Girls in Bangalore  GIUXUZ...
Bangalore call girl 👯‍♀️@ Simran Independent Call Girls in Bangalore GIUXUZ...
 
VIP Call Girls Lucknow Isha 🔝 9719455033 🔝 🎶 Independent Escort Service Lucknow
VIP Call Girls Lucknow Isha 🔝 9719455033 🔝 🎶 Independent Escort Service LucknowVIP Call Girls Lucknow Isha 🔝 9719455033 🔝 🎶 Independent Escort Service Lucknow
VIP Call Girls Lucknow Isha 🔝 9719455033 🔝 🎶 Independent Escort Service Lucknow
 

Clinical Implications of Oral Anti-Coagulants

  • 1. Clinical Implications of Oral Anti-Coagulants Focus on Atrial Fibrillation Brad Angeja, MD FACC Palo Alto Medical Foundation
  • 3. Relevant Advances in Atrial Fibrillation • Why anti-coagulate? – Calculate stroke risk • Data for warfarin • Rationale for warfarin alternatives – Data for the NOACs – Idiosyncrasies of the NOACs • Special topics – Elderly, peri-operative, valves, reversal Objectives
  • 4. Clinical Uses of Anti-coagulation • DVT, PE (discussed separately) • Mechanical valves • Atrial fibrillation – 2.7 million American adults – and counting – 12% 75 to 84 years of age – >1/3 ≥80 years of age – Lifetime risk after 40 years of age is about 25% • Stroke in AF – 15% of all strokes in the US can be attributed to AF, – 5 fold increased risk of stroke and – the results of stroke are worse 1 ,3 1. Nattel. Lancet 2006;367:262-272 2. Page. N Engl J Med 2004;351:2408-16 3. HRS guidelines 2014 Slide courtesy Chris Woods, MD
  • 5. Stroke is caused by thromboembolic disease in AF 5 90% of thrombi are found in the Left atrial appendage Slide courtesy Chris Woods, MD
  • 6. Transesophageal Echocardiogram of the Appendage 6 Normal With Clot Slide courtesy Chris Woods, MD
  • 10. Bleeding Risk: HAS-BLED 10 Clinical characteristics comprising the HAS-BLED Bleeding Risk Score Letter Clinical characteristic* Points HAS-BLED score Bleeds per 100 patient-yrs H Hypertension (ie uncontrolled blood pressure) 1 0 1.13 A Abnormal renal and liver function (1 point each) 1 or 2 1 1.02 S Stroke 1 2 1.88 B Bleeding tendency or predisposition 1 3 3.74 L Labile INRs (for patients taking warfarin) 1 4 8.70 E Elderly (age greater than 65 years) 1 5 to 9 Insufficient data D Drugs (aspirin or NSAIDs) or alcohol abuse (1 point each) INR: international normalized ratio; NSAIDs: nonsteroidal anti-inflammatory drugs.
  • 11. “There’s an app for that” • Online and smartphone calculators • https://itunes.apple.com/us/app/anticoagevaluato r/id609795286?mt=8 11
  • 12. 12
  • 13. 13
  • 14. Warfarin works, but… • Bleeding risk • Lab monitoring • Drug interactions • Food interactions • Infrastructure – Coumadin clinic • Compliance Enter: NOACs • Novel Oral Anti-Coags 14
  • 15. The Challenge for NOACs • Must be – better than warfarin, and/or – safer than warfarin, and/or – more convenient than warfarin • At least enough to justify the cost • For all it’s problems, warfarin sets a high bar – 2/3 risk reduction – Works for 2/3 of patients (INR at target) – Cheap 15
  • 16. 18,113 CHADS 2 Slide courtesy Chris Woods, MD
  • 18. 18,201 CHADS 2 Slide courtesy Chris Woods, MD
  • 19. RE-LY Dabigatran 110 mg 1.53% per year Dabigatran 150 mg 1.11% per year Warfarin 1.69% per year ROCKET AF Rivaroxaban 20mg 1.7% per year (2.1) Warfarin 2.2% per year (2.4) (HR = 0.88) (P=0.12 ITT) ARISTOTLE Apixaban 5 mg 1.27% per year Warfarin 1.60% per year Primary Endpoint of Stroke or Systemic Embolism: Non-inferiority Analysis p<0.001 p<0.001 p<0.001 Non Inferiorirty p vs warfarin ITT Analysis Modified ITT No ITT analysis is available for non-inferiority in Rocket AF. An on treatment or per-protocol analysis is generally performed in the assessment of non-inferiority. If numerous patients come off of study drug, this biases the trial towards a non-inferior result in an ITT analysis. This is the basis for performing a per-protocol analysis in a non-inferiority assessment. C. Michael Gibson, M.S., M.D. p<0.001 ITT Analysis Patel MR et al, NEJM 2011; Connolly SJ, et al. N Engl J Med. 2009;361:1139-1151; Granger C et al, N Eng J Med; 2011 HR = 0.79 HR = 0.79 HR = 0.91 HR = 0.66 Slide modified from Chris Woods, MD
  • 20. 20 All Cause Stroke Ischemic Stroke Hemorrhagic stroke Slide courtesy Chris Woods, MD
  • 21. All Cause Mortality favors NOAC Dabigatran 110 mg 3.75% / yr 0.91 0.35 Dabigatran 150 mg 3 .64% / yr 0.88 0.051 Warfarin 4.13% / yr HR ITT p-value Rivaroxaban 20 mg 4.52% / yr 0.92 0.152* Warfarin 4.91% / yr ROCKET RELY C. Michael Gibson, M.S., M.D. *In an on treatment analysis in Rocket AF mortality rates were 1.87% / yr for rivaroxaban and 2.21% / yr for warfarin, p=0.073. No on treatment analysis is available from RE-LY. Apixaban 5 mg 3.52% / yr 0.89 0.01 Warfarin 3.94% / yr ARISTOTLE Patel MR et al, NEJM 2011; Connolly SJ, et al. N Engl J Med. 2009;361:1139-1151; Granger C et al, N Eng J Med; 2011 95% CI 0.89 (0.80, 0.998) N=448 events planned, 480 in trial Slide courtesy Chris Woods, MD
  • 22. 22 Efficacy • Eliquis • Pradaxa • Xarelto Convenience • Xarelto • Eliquis • Pradaxa Safety • Eliquis • Xarelto • Pradaxa
  • 23. 23
  • 24. 24
  • 25. 25
  • 26. Safety concerns re: Pradaxa • GI side effects in 25-35% – Including significantly more GI bleeding • Not advised in patients over 80 • 75 mg “dose adjustment” for renal dysfunction – Not validated in Re-Ly! – Generally avoid this agent if CrCl is under 30 • Small increase in MI risk? – Did not reach statistical significance – But – I have seen 2 cases… 26
  • 27. Fewer safety concerns re: Xarelto • No GI side effects • Acceptable in patients over 80 • Dose adjustment for renal dysfunction – 15mg daily if CrCl is 15-50 – Must calculate Cockcroft-Gault! • Estimated GFR from lab varies from CrCl 27
  • 28. Fewest safety concerns re: Eliquis • No GI side effects • Acceptable in patients over 80 • Dose adjustment if any 2 of 3 are present: – Renal dysfunction (Cr > 1.5) • Including ESRD (although still consider warfarin) • No need to calculate Cockcroft-Gault – Weight under 60kg – Age > 80 28
  • 29. 29 Efficacy • Eliquis • Pradaxa • Xarelto Convenience • Xarelto • Eliquis • Pradaxa Safety • Eliquis • Xarelto • Pradaxa I favor Eliquis unless: • Once-daily preferred • Formulary requires
  • 30. Special Considerations: Peri-operative • Low-bleed risk – Continue if possible • Intermediate risk – Stop the day prior • High bleed risk – Stop 2 days prior • Refer to manufacturer recommendations • Ask us! • Warfarin, Eliquis, Xarelto, plavix, ASA, prasugrel… • No “one size fits all” for pre-op! – Old standard: • “Stop blood thinners 1 week prior” – In 2015: • “Please consult with the prescribing physician” 30
  • 31. Special Considerations: Bleeding • “Warfarin can be reversed, NOACs cannot” – How effective is plasma and Vit K anyway? – Short half-life – NOACs “wear off” quickly – No antidote in the clinical trials of NOACs, and they were equal to or better than warfarin bleed risk! – Reversal agents are on the way 31
  • 32. Special Considerations: Warfarin only • Valvular AF – In particular when the AF is related to the valve (mitral) – Less strict if the valve is dissociated from the AF (AS) • Mechanical valves • “Triple Therapy” – AF with high CVA risk PLUS recent ACS or stent – Aspirin, plavix, warfarin – best determined by interventional cardiologist 32
  • 33. Making the switch • Warfarin to NOACs – Stop warfarin – INR drifts down; intend to start NOAC when INR < 2 • Measure every day, or • Typically skip 2 days if INR has been predictable 2.5 • NOACs to warfarin – More complicated – Generally requires enoxaparin to replace the NOAC while warfarin gets to INR > 2 • NOACs can affect INR 33
  • 34. Relevant Advances in Atrial Fibrillation • Anti-coagulation reduces stroke risk in AF – CHADS-VASC and HAS-BLED – “There’s an app for that” • Warfarin is very good – NOACs are better – Eliquis > Xarelto > Pradaxa – Except valves and “triple therapy” • Peri-op – tailor the “holiday” to the agent! Summary